Arkolith/Insider Trading/KTRA/Form 4

Bianco James A.

Chief Executive Officer, DirectorKintara Therapeutics, Inc. (KTRA) · full profile →Form 4 · filed Oct 22, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 18, 2024Grant(A)2.3M—$02.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 18, 2024Grant(A)72K—$072K
Oct 18, 2024Grant(A)358K—$0358K
Oct 18, 2024Grant(A)191K—$0191K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000897069-24-001996) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML